How many investments has NSG Ventures made?

NSG Ventures has 25 tracked investments, 5 of which have exited.

What stage does NSG Ventures invest at?

NSG Ventures invests at the Seed, Series A stages.

What sectors does NSG Ventures focus on?

NSG Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.

Where is NSG Ventures located?

NSG Ventures is headquartered in Singapore, SG.

Who does NSG Ventures co-invest with?

NSG Ventures most often shares deals with New Enterprise Associates (NEA), Lux Capital, Menlo Ventures, among 41 tracked co-investors.

NSG Ventures

Venture capital

Singapore · Seed–Series A · 10 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into NSG Ventures

1,780 people in our graph share verified history with the NSG Ventures team — schools, employers, funds. One of them is your warm intro.

Chris Bischoffunlockedknows Daphne Teo · together at Goldman Sachs (overlapped)

×2knows the team · via Stanford University

×5knows the team · via Goldman Sachs

×2knows the team · via Imperial College London

knows the team · via HSBC

knows the team · via Raffles Institution

✨ Fox Verdict

Investment thesis

NSG Ventures focuses on biotechnology and the treatment of human disease, investing in innovative scientific solutions to major health problems. Managed by founders and scientists, the firm partners with exceptional teams for the long term to push scientific boundaries and enable medical breakthroughs.

Invests inBiotech Digital Health Healthtech Medical Devices Asia-Pacific China Global North America Singapore Singapore United States

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Series A

Singapore, SG

Instruments

Equity

Founded

2021

Tracked investments

IPOs

Team · 10 people

from the firm's website & curated & public directories

Jeffrey Lu· Founding Partner

Technology and healthcare entrepreneur who co-founded Engine Biosciences and held senior roles at AAE, AirAsia, Goodman Capital and Bain & Company. Has made investments across healthcare, biotech and internet companies. Graduated summa cum laude from the University of Pennsylvania.

Timothy Lu· Founding Partner

Synthetic biology expert and serial biotech entrepreneur serving as Chief Scientific Advisor of NSG Ventures. Co-founded multiple companies including Tango Therapeutics, Senti Biosciences, and Synlogic, and is an MIT professor. Holds an M.D. from Harvard and a Ph.D. from MIT.

Daphne Teo· Founding Partner· Singaporein

Founder and CEO of NSG Ventures and NSG BioLabs, with over a decade of experience across real estate, biotech, and investment banking. Co-founder of Engine Biosciences and Chief Investment Officer of D3 Capital, previously at Goldman Sachs and HSBC.

d•••@nsg.venturesreveal

Jeffrey Lu· Founding Partner· Singaporein

Jeffrey Lu is co-founder and CEO of Engine Biosciences. Over 15 years, he has founded and led technology and life sciences companies across APAC and the US, including Enleofen (acquired by Boehringer Ingelmann for $4 billion) and AAE (acquired by Expedia), developing clinical therapeutics, AI and data-driven platforms, and generating exits and capital returns. He has also invested as a venture capital partner and principal investor in life sciences and AI-enabled technologies, and has experience across company formation, team building, capital raising, product development, and transaction execution.

Ken Nesmith· Venture Partner

Healthcare and life sciences technologist and executive; currently CBO of the oncology business at Lunit and formerly co-founder and CEO of Lexent Bio (acquired by Foundation Medicine). Completed studies at MIT and an MBA at Wharton.

Paul Lin· Venture Partner

Life sciences and technology executive with over 20 years' experience, formerly COO at Plexxikon where he led IND filing for vemurafenib/Zelboraf. Holds dual M.D. and M.B.A. degrees from the University of Pennsylvania.

Cheryl Cui· Advisor

Biomedical engineer focused on identifying promising technologies and working with founders. Former Venture Partner at VentureHealth and co-founder of an acquired mobile health company. Holds a joint PhD from MIT and Harvard Medical School.

Darin Baur· CFO

Corporate finance and legal executive with over 20 years' experience leading financings and M&A across Asia, the U.S., Australia and Europe. Began as an attorney at Skadden Arps and held investment banking roles at Citigroup, HSBC and Canaccord Genuity. Holds a J.D. from Harvard Law.

David Epstein· Advisor

Biopharmaceutical leader and founder of Black Diamond Therapeutics, which he took public on NASDAQ. Former Vice Dean of Innovation & Entrepreneurship at Duke-NUS and former CSO of OSI Pharmaceuticals. Holds a Ph.D. in Biochemistry from Brandeis University.

Fiona Lee· Advisor· Singaporein

Trained bench scientist working across neuroscience, skin biology, stem cells and oncology who functions as an Investment Associate at NSG, performing due diligence and writing investment memos. Holds a DPhil from Oxford and a bachelor's from Imperial College London.

Founder mafia

2 people who came through NSG Ventures went on to found or lead other companies.

Daphne TeoFounding PartnerFounded NSG Bio Timothy LuFounding PartnerFounded Senti Biosciences

What they invest in

from 15 of 25 portfolio companies

Biotech ×12Deep Tech ×7AI & Machine Learning ×6Medical Devices ×5Digital Health ×2Healthtech ×2PropTech ×2Advanced Manufacturing ×1

HQs:United States×5Singapore×3China×1United Kingdom×1

Investments · 25 tracked

founders shown can be your intro path

BiomXbiomx.com in 𝕏NYSE: PHGE

BiomX builds a portfolio of defense and security companies through subsidiaries, partnerships, and acquisitions, focusing on detection systems, aerial technologies, and infrastructure security.

AI & Machine LearningBiotechCybersecurityDeep TechDefense TechHardware

Jonathan Solomon(Chief Executive Officer)inMerav Bassan(Chief Development Officer)in Marina Wolfson(Chief Financial Officer)inJesse Goodman(Director)Alan Moses(Director)Jonathan Leff(Director)

Co-investorsAMR Action Fund Baruch Future Ventures OrbiMed 8VC

Black Diamond Therapeutics, Incblackdiamondtherapeutics.comNASDAQ: BDTX

Black Diamond Therapeutics develops small-molecule kinase inhibitors targeting families of oncogenic mutations across cancer types, including its lead candidate silevertinib for EGFR-mutant lung cancer and glioblastoma.

Elizabeth Buck(Chief Scientific Officer)inBrent Hatzis-Schoch(Chief Operating Officer and General Counsel)inSergey Yurasov(Chief Medical Officer)inMelanie Morrison(Chief Development Officer)

Co-investorsLAV Lilly Asia Ventures New Enterprise Associates (NEA)Nextech Invest RA Capital Versant Ventures +3 more

Senti Biosciencessentibio.com in 𝕏NASDAQ: SNTI

Senti Bio develops cell and gene therapies for cancer and difficult-to-treat diseases using synthetic biology and engineered Gene Circuits to enhance precision, control, and selectivity in targeting tumor cells.

BiotechDeep TechMedical DevicesSouth San Francisco, US

Tim Lu(Co-Founder and Chief Executive Officer)in Philip Lee(Executive Officer)inKanya Rajangam(President, Head of Research & Development and Chief Medical Officer)inYvonne Li(Executive Officer)inJames Collins(Director)

BoardDonald Tang(Director)

Co-investorsEvolution VC Partners Flucas Ventures Lifeforce Capital Lux Capital Menlo Ventures New Enterprise Associates (NEA)+10 more

Synlogicsynlogictx.com in 𝕏OTC: SYBX

Synlogic develops synthetic biology-based biotherapeutics that use engineered living organisms to treat diseases.

BiotechDeep TechMedical DevicesCambridge, US

Bharatt Chowrira(Executive Officer)inMichael Sheahan(Executive Officer)Jose Carlos Gutierrez-Ramos(Executive Officer, Director)in Paul Miller(Executive Officer)inAoife Brennan(Executive Officer)inTodd Shegog(Executive Officer)in

Co-investorsAtlas Venture New Enterprise Associates (NEA)Pfizer Venture Investments Sofinnova Ventures Solasta Ventures OrbiMed

Tango Therapeuticstangotx.comNASDAQ: TNGX

Tango Therapeutics develops genetically targeted medicines using synthetic lethality principles to treat specific tumors.

BiotechBoston, US

Alan Huang(Executive Officer)in Adam Crystal(Executive Officer)inDaniella Beckman(Executive Officer)inDouglas Barry(Executive Officer)Aaron Davis(Director)

Board Barbara Weber(Executive Officer, Director)in

Co-investorsForesite Capital Nextech Invest Third Rock Ventures

Biotixbiotix.bio

Biotix develops natural, sustainable skincare ingredients derived from skin microbiome microbes, using an AI platform alongside biology experiments to identify and test ingredients for efficacy and safety.

AI & Machine LearningBiotechWellness & Fitness

Bota Biobota.bio

Bota offers engineered protein solutions through strain optimization and screening, leveraging proprietary datasets to increase protein yield while reducing production costs for industrial biotech applications.

Advanced ManufacturingBiotechDeep TechFoodTechNew Materials

Dr. Cheryl Cui(CEO)

Co-investorsHongShan Capital Group Source Code Capital Matrix Partners China Sherpa Healthcare Partners

Cognito Healthcognitohealth.com in

Cognito Health is a medical device manufacturer that uses predictive algorithms to provide contact-free patient monitoring, forecasting adverse events such as falls and pressure injuries before they occur.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Co-investorsGraphite Ventures Garage Capital Simplex Ventures Spring Impact Capital StandUp Ventures

Corviumcorvium.com

Jeff Swartzin

Co-investorsAcre Venture Partners Canaan Partners Cultivian Sandbox Ventures

Eligo Bioscienceeligo.bio in 𝕏

Eligo Bioscience is a genetic engineering company pioneering synthetic biology approaches using CRISPR and phage biology to develop therapeutics.

AI & Machine LearningBiotechDeep TechHealthtechMedical Devices

David Bikard(Scientific Founder)Benoit Barteau(Scientific Cofounder)Nessan Bermingham(Scientific Cofounder)Laia Crespo-Martin(Scientific Cofounder)Xavier Duportet(CEO)

Co-investorsSanofi Ventures VIVES Partners

Engine Bioenginebio.com

Engine Bio presents itself as a company working on new cancer medicines.

BiotechSingapore, SG

Daphne Teo(Founder)in

Foundation Medicinefoundationmedicine.com in 𝕏

Foundation Medicine is a precision medicine company that develops comprehensive genomic profiling and companion diagnostic tests for cancer and other diseases.

BiotechDigital HealthMedical DevicesBoston, US

Co-investorsGV (Google Ventures)Khosla Ventures Kleiner Perkins

Medramedra.ai in 𝕏

Medra builds robotic systems integrated with AI, computer vision, and natural language processing to automate data collection for life science research.

AI & Machine LearningBiotechDeep TechRoboticsSan Francisco, US

Michelle Lee(Co-founder)in

Co-investorsCarbon Silicon Fifty Years Fusion Human Capital Lux Capital Menlo Ventures +4 more

NSG Bionsgbio.com in

NSG Bio operates BSL-2 certified co-working wet-laboratory and office spaces for life sciences and biotech companies in Singapore, offering turnkey facilities, shared equipment, and support services for startups and multinationals conducting R&D.

BiotechPropTechSingapore, SG

Daphne Teo(Founder)in

Co-investorsClavystBio

Open Proteinopenprotein.ai in 𝕏

OpenProtein.AI offers protein language models and AI infrastructure for protein engineering, covering de novo sequence design, variant effect prediction, in silico screening, and training specialized models on proprietary data.

AI & Machine LearningBiotechDeep Tech

Tristan Bepler in

Co-investorsThe E14 Fund

Restorbiorestorbio.com 𝕏

The site is an affiliate-driven blog publishing beauty, hair care, and skincare product comparisons and reviews for consumers.

ConsumerMedia & Entertainment

Zuzuzuzuhospitality.com

ZUZU Hospitality provides property management software and revenue management tools for independent hotels, combining automated pricing, distribution across OTAs, and reservation management with human expertise.

PropTechSaaSTravel & HospitalitySingapore, SG

Co-investorsAC Ventures Golden Gate Ventures Latin Leap Vulpes Ventures Wavemaker Partners Z Venture Capital +2 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

88 RisingAslanBlack DiamondEnleofenLexentPairXBioSentiTango

Exits · 5

5 IPOs

BiomXNYSE: PHGEBlack Diamond Therapeutics, IncNASDAQ: BDTXSenti BiosciencesNASDAQ: SNTISynlogicOTC: SYBXTango TherapeuticsNASDAQ: TNGX

Portfolio news

latest coverage across their companies

Black Diamond Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference

Black Diamond Therapeutics, Inc · finance.yahoo.com · Sep 2, 2026

Roche Acquires Foundation Medicine | Acquiry Deal Intelligence

Foundation Medicine · acquiry.com · Aug 23, 2026

BiomX Inc. SEC Filing (Aug 14, 2026) | PHGE NT 10-Q

BiomX · stocktitan.net · Aug 14, 2026

Senti Biosciences (NASDAQ:SNTI) to spin off SENTI-202 pipeline to Celadon-backed NewCo via CVRs

Senti Biosciences · kalkine.com.au · Jul 31, 2026

Mizuho raises Tango Therapeutics stock price target on combo data By Investing.com

Tango Therapeutics · investing.com · Jul 17, 2026

Medra Raises $52M, Partners With Genentech

Medra · hlth.com · Dec 15, 2025

Deals in brief: RushOwl and Zuzu raise funding, Airwallex acquires OpenPay, nine new China investments, and more

Zuzu · kr-asia.com · Sep 4, 2025

Frequently asked questions

How many investments has NSG Ventures made?: NSG Ventures has 25 tracked investments, 5 of which have exited.
What stage does NSG Ventures invest at?: NSG Ventures invests at the Seed, Series A stages.
What sectors does NSG Ventures focus on?: NSG Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is NSG Ventures located?: NSG Ventures is headquartered in Singapore, SG.
Who does NSG Ventures co-invest with?: NSG Ventures most often shares deals with New Enterprise Associates (NEA), Lux Capital, Menlo Ventures, among 41 tracked co-investors.

Images

Similar investors

US Venture Partners

US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.

$500K – $10M

Wavemaker Three-Sixty Health

Wavemaker 360 is a healthcare-focused venture capital firm that backs entrepreneurs building disruptive companies transforming the healthcare industry. Its limited partners are largely individuals with significant healthcare industry experience.

$500K – $2M

HealthQuad

HealthQuad is a healthcare-focused investment firm that partners with entrepreneurs building category-defining healthcare businesses, leveraging its healthcare network and clinical/operating expertise.

Next Ventures

Next Ventures is an investment firm that backs founders building solutions to improve health care access and enhance human capability.

$500K – $3M

CABHI Ventures

CABHI (Centre for Aging + Brain Health Innovation) is a pan-Canadian organization that funds and supports researchers, innovators, and startups working on brain health and aging solutions, and helps healthcare and community organizations adopt them.